
Sign up to save your podcasts
Or


At the start of 2020, Barry Wark and the team at Ovation.io were on a growth path – not even they could envision 75x usage growth they ended up seeing. Madrona investor, Chris Picardo, talks to Barry about the year and how the incredible amount of genomic data created by COVID testing will be a tailwind to academics, researchers and others looking for treatment and cures for disease.
By Madrona Ventures4.8
1212 ratings
At the start of 2020, Barry Wark and the team at Ovation.io were on a growth path – not even they could envision 75x usage growth they ended up seeing. Madrona investor, Chris Picardo, talks to Barry about the year and how the incredible amount of genomic data created by COVID testing will be a tailwind to academics, researchers and others looking for treatment and cures for disease.

534 Listeners

2,453 Listeners

1,094 Listeners

3,139 Listeners

30,190 Listeners

2,165 Listeners

227 Listeners

10,024 Listeners

5,526 Listeners

131 Listeners

636 Listeners

474 Listeners

42 Listeners

42 Listeners

37 Listeners